NCBiotech News

The National Science Foundation has just awarded Johnston Community College a $283,880 grant to train technicians for jobs at major biomanufacturing plants in the area.

Early buyers were willing to pay a premium today to own a piece of Durham-based Precision BioSciences.

Mayne Pharma, a developer and manufacturer of pharmaceuticals, which opened a new $80 million Greenville facility in 2018, is launching the Mayne Scholarship program at Pitt Community College (PCC) this fall.

Paris-based biotechnology company Cellectis announced plans today to invest nearly $70 million and create 200 jobs in Raleigh, at what will become its first North American manufacturing facility.

Durham-based Precision BioSciences, a genome-editing company focused on creating better foods and medicines, wants to raise up to $100 million in an initial public offering (IPO) of stock.

CiVentiChem has received its first U.S. Food and Drug Administration approval for a generic commercial active pharmaceutical ingredient (API) manufactured at its Cary headquarters.

Glenmark Pharmaceuticals, the largest pharmaceutical manufacturer in the Greater Charlotte region, is bringing a big “Help Wanted” message to the North Carolina Biotechnology Center’s monthly Jobs Network event, in search of production employees to help meet its fast-growing demand.

New entrants to the biomanufacturing industry recently described for an enthusiastic audience at an NCBiotech event that they're experiencing incredible opportunity, thanks to North Carolina's workforce training system and excellent pool of grateful employers.

Seqirus, already the world’s largest producer of cell-based influenza vaccines, is about to grow even larger due to strong global demand for its quadrivalent flu vaccine.

bluebird bio, a gene therapy company with operations in Durham, has passed a regulatory milestone for its potential treatment of an inherited blood disorder.

Grifols, a global biotherapeutics company with major operations in North Carolina, has received approval from the U.S. Food and Drug Administration for a new formulation of GamaSTAN, its medicine for treating patients who’ve been exposed to the hepatitis A or measles viruses.

Hernan Navarro, Ph.D., retired chief scientist for RTI International’s Center for Drug Discovery, has returned to the workplace to direct the Biomedical Research Institute and Technology Enterprise (BRITE) at North Carolina Central University in Durham. 

Glenmark Pharmaceuticals, an India-based global pharmaceutical company, has received its first U.S. Food and Drug Administration go-ahead to market one of its North Carolina-made drugs in the United States.

The United States Green Building Council has awarded Grifols’ newly built administration building the Leadership in Energy and Environmental Design (LEED) Silver certification -- the second of the company’s buildings on its Johnston County campus to receive LEED certification.

Pitt County Development Commission and partner counties and organizations are packaging an“Active Site” theme and taking it on the road, to make sure the region is on the radar of any pharmaceutical company planning an expansion or a new manufacturing facility.